Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1Areceptor activation

Citation
J. Ichikawa et Hy. Meltzer, Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1Areceptor activation, EUR J PHARM, 380(1), 1999, pp. R1-R3
Citations number
8
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
380
Issue
1
Year of publication
1999
Pages
R1 - R3
Database
ISI
SICI code
0014-2999(19990903)380:1<R1:VACIPD>2.0.ZU;2-B
Abstract
The anticonvulsant mood stabilizers valproic acid (250, 500 but not 50 mg/k g) and carbamazepine (6, 12.5 but not 3 mg/kg) were found to increase extra cellular dopamine levels in rat medial prefrontal cortex, but not nucleus a ccumbens. Increased prefrontal dopamine was completely abolished by the sel ective 5-HT1A receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]e thyl]-N-2-pyridinyl-cyclohexanecarboxamide (WAY100635, 0.05 mg/kg). Anticon vulsants and clozapine may share a common mood stabilizing mechanism since clozapine is reported to have mood stabilizing effects and increase prefron tal dopamine by 5-HT1A receptor activation. (C) 1999 Elsevier Science B.V. All rights reserved.